Health Care & Life Sciences » Biotechnology | OncoSil Medical Ltd.

OncoSil Medical Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
7,088.70
6,120.30
13,039.10
8,000.60
15,205.20
Total Accounts Receivable
136.80
75.10
2,627.90
3,529.40
4,482.80
Other Current Assets
2,391.10
1,156.70
138.20
159.40
108.00
Total Current Assets
9,616.50
7,352.10
15,805.30
11,689.40
19,796.10
Net Property, Plant & Equipment
16.60
55.10
91.70
115.50
86.30
Total Assets
9,633.10
7,407.10
15,897.00
11,804.90
19,882.30
Accounts Payable
36.40
170.90
216.70
901.30
857.10
Other Current Liabilities
84.30
274.80
869.60
768.80
870.50
Total Current Liabilities
120.70
445.70
1,086.30
1,670.10
1,727.60
Total Liabilities
120.70
445.70
1,086.30
1,670.10
1,727.60
Common Equity (Total)
9,512.40
6,961.40
14,810.70
10,134.80
18,154.70
Total Shareholders' Equity
9,512.40
6,961.40
14,810.70
10,134.80
18,154.70
Total Equity
9,512.40
6,961.40
14,810.70
10,134.80
18,154.70
Liabilities & Shareholders' Equity
9,633.10
7,407.10
15,897.00
11,804.90
19,882.30

About OncoSil Medical

View Profile
Address
50 Berry Street
North Sydney New South Wales (NSW) 2060
Australia
Employees -
Website http://www.oncosil.com.au
Updated 07/08/2019
OncoSil Medical Ltd. develops and commercializes neurology services, including those for pancreatic cancer. It is engaged in the development of novel and safer radiation therapy treatments. The company was founded by David McAuliffe on April 14, 2005 and is headquartered in North Sydney, Australia.